Related Experiment Video
Updated: Feb 19, 2026

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
8.2K
Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from
Dimitry A Chistiakov1,2, Yuri V Bobryshev3,4, Vladimir P Chekhonin1,2
1Department of Basic and Applied Neurobiology, V.P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia.
Current Pharmaceutical Design
|November 1, 2017
Summary
Chronic stress causes lasting epigenetic changes in the brain, leading to depression-like behaviors. Epigenetic antidepressants can reverse these stress-induced changes.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Epigenetic modifications regulate gene expression and are implicated in neuropsychiatric disorders like depression.
- Chronic stress in rodent models induces behavioral and cognitive deficits resembling human depression.
- Early life stress can lead to persistent, transgenerational alterations in stress responses and behavior.
Purpose of the Study:
- To investigate the role of epigenetic mechanisms in stress-induced depression.
- To explore how chronic stress affects brain function and behavior in animal models.
- To examine the potential of epigenetic therapies in reversing stress-induced abnormalities.
Main Methods:
- Utilizing rodent models exposed to chronic social stress (prenatal/postnatal).
- Analyzing epigenetic changes in specific brain regions, particularly the limbic system.
- Assessing behavioral and cognitive impairments, including memory and learning deficits.
- Evaluating the effects of epigenetically active antidepressants.
Main Results:
- Chronic stress induces stable, long-lasting epigenetic modifications in limbic brain regions.
- These epigenetic changes correlate with persistent behavioral abnormalities and cognitive deficits.
- Stress-induced alterations and their epigenetic signatures can be transmitted across generations.
- Epigenetic antidepressants effectively disrupt abnormal epigenetic programming and restore resilient patterns.
Conclusions:
- Epigenetic modifications are key mediators of chronic stress effects on brain function and behavior.
- Rodent models of chronic stress provide valuable insights into the molecular mechanisms of depression.
- Epigenetic therapies hold promise for treating depression by reversing maladaptive stress-induced programming.
Related Concept Videos
Human Genetics
1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Depressive Disorders: Etiology
748
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
748
Antidepressant Drugs: MAOIs and Other Agents
975
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
975

